France's Sanofi to boost Pfizer vaccine supply amid EU shortages
Pfizer-BioNTech has cited production problems, as has AstraZeneca, which is also falling behind in its EU deal
French drug maker Sanofi has said it will help mass produce the coronavirus vaccine developed by Pfizer/BioNTech, amid EU shortages.
Sanofi says it has struck a deal to produce 125 million doses of the vaccine by the end of the year, reports the BBC.
Pfizer-BioNTech has cited production problems, as has AstraZeneca, which is also falling behind in its EU deal.
Keep updated, follow The Business Standard's Google news channel
The EU has threatened to restrict the exports of vaccines made within the bloc to deal with the shortfall.
Sanofi's chief executive said the contract with Pfizer was a first in the pharmaceutical industry and it comes after the French firm delayed the launch of its own jab.
The Germany-based BioNTech will initially produce the vaccines at Sanofi facilities in Frankfurt, starting in July, according to a Sanofi statement.
